Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in β3 Subunits.
<p>See <b><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0336606#pone.0336606.g003" target="_blank">Fig 3</a></b> legend for detailed description. Protection was inferred when an anesthetic significantly reduced modification ra...
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Eará dahkkit: | |
| Almmustuhtton: |
2025
|
| Fáttát: | |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
| Čoahkkáigeassu: | <p>See <b><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0336606#pone.0336606.g003" target="_blank">Fig 3</a></b> legend for detailed description. Protection was inferred when an anesthetic significantly reduced modification ratios (p < 0.05) relative to control. Below each bar graph is a diagram showing the interfaces where the mutation is located. <b>Panel A:</b> β3L231C (β–) was protected by both R-mTFD-MPAB and pTFD-di-iPr-BnOH. <b>Panel B:</b> β3M286C (β+) was protected by etomidate. ETO = etomidate; MPAB = R-mTFD-MPAB; iPr-BnOH = pTFD-di-iPr-BnOH; pCMBS = para-chloromercuribenzenesulfonate.</p> |
|---|